Product Code: 27EL-712-2035
Please note: This is a Single Viewer eCast registration for one participant for this eCast for both the live and on-demand version of this eCast. If you are interested in presenting this program to a group, please see the “eCast Registration Form– Group Viewing” form on the eCast program page.
Access instructions for the live eCast will be provided via email approximately 2-3 business days prior to the live program date. Access instructions for the on-demand version of this program will be provided via email approximately 3-10 business days after the live program has occurred and the on-demand version is available.
Program Description: Transfusion-transmitted malaria (TTM) remains a rare but potentially fatal complication of blood transfusion. Despite established donor screening protocols, cases continue to occur with diagnostic delays that can lead to severe patient outcomes including multiorgan failure and death. Clinicians in non-endemic regions often maintain low suspicion for malaria in transfusion recipients, while blood establishment professionals face evolving FDA guidance to reduce the risk of TTM. These knowledge and practice gaps span the transfusion medicine continuum, affecting physicians, laboratory scientists, quality professionals, and nursing staff who share responsibility for TTM prevention, detection, and response.
This program utilizes an interactive lecture format combined with clinical case studies to address these gaps. An infectious diseases physician/malariologist will present cases of nosocomial malaria transmission, including a TTM fatality, illustrating clinical presentation patterns, diagnostic challenges, and investigation workflows. A blood establishment quality systems director will then review the status of FDA guidance to reduce the risk of TTM, the operational aspects of donor lookback processes, and regulatory reporting requirements. Through this interprofessional approach, participants will gain practical knowledge to recognize TTM promptly, to implement approaches to reduce the risk of TTM (e.g., selective donation testing) and coordinate effective responses across clinical and blood bank teams.